Andrew John Partridge - Insider Trading & Ownership

Entity
Individual
Location
C/O Centrexion Therapeutics Corporation, 200 State Street, Boston, MA
Summary
The estimated net worth of Andrew John Partridge is at least $2.92M dollars as of February 11, 2022. Andrew John Partridge is the EVP & Chief Commercial Officer of Turning Point Therapeutics, Inc. and owns shares of Turning Point Therapeutics, Inc. stock worth about $2.92M.
All Insider Reports
All Insider Reports

Ownership of Andrew John Partridge

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TPTX Turning Point Therapeutics, Inc. EVP & Chief Commercial Officer $2.92M Feb 9, 2022

Insider Transactions Reported by Andrew John Partridge:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.